Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Mulls Adding Insect Repellent Combinations To Sunscreen Monograph

This article was originally published in The Tan Sheet

Executive Summary

If FDA decides to include combination insect repellent/sunscreen drug products in the sunscreen monograph, some products could be forced to file new drug applications or face removal from the market
Advertisement

Related Content

Dual Label Meets Repellent/Sunscreen Requirements By FDA, EPA – Chattem
Dual Label Meets Repellent/Sunscreen Requirements By FDA, EPA – Chattem
Dual Label Meets Repellent/Sunscreen Requirements By FDA, EPA – Chattem
Sunscreen/Repellent Comments Stress Aligning FDA, EPA Label Regs
Sunscreen/Repellent Comments Stress Aligning FDA, EPA Label Regs
Sunscreen/Repellent Comments Stress Aligning FDA, EPA Label Regs
Sunscreen/Insect Repellent Combinations Should Be Monographed – CTFA
OTC Monograph Route More Onerous Than NDA Process – ONP Official
"SPF 30 Plus" Term Required For High-Protection Sunscreens - FDA Final Reg
"SPF 30 Plus" Term Required For High-Protection Sunscreens - FDA Final Reg
Advertisement
UsernamePublicRestriction

Register

PS100248

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel